Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6361 to 6375 of 9008 results

  1. Saving babies' hearing: how a world-first rapid genetic test is transforming neonatal care

    Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 babies' hearing so far with potential to prevent hearing loss in 200 babies annually.

    News
    Last updated
    23 March 2026

  2. International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis

    Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits for patients

    News
    Last updated
    19 March 2026

  3. Patients to get new medicines up to 6 months sooner

    A new aligned pathway between NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) will help bring medicines to patients faster.

    News
    Last updated
    19 March 2026

  4. Improving outcomes in haemato-oncology cancer (CSG3)

    This guidance has been updated and replaced by NICE guideline NG47.

    Withdrawn guideline

  5. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

    Withdrawn guideline

  6. Transanal total mesorectal excision of the rectum (IPG514)

    This guidance has been updated and replaced by NICE HealthTech guidance 603.

    Withdrawn guidance

  7. Irreversible electroporation for treating prostate cancer (IPG768)

    We have moved interventional procedures guidance 768 to become HealthTech guidance 688. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  8. Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation (IPG805)

    We have moved interventional procedures guidance 805 to become HealthTech guidance 752. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  9. MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's (IPG796)

    We have moved interventional procedures guidance 796 to become HealthTech guidance 733. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. MRI-guided focused ultrasound subthalamotomy for treating Parkinson's (IPG797)

    We have moved interventional procedures guidance 797 to become HealthTech guidance 734. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Pulsed-field ablation for atrial fibrillation (IPG806)

    We have moved interventional procedures guidance 806 to become HealthTech guidance 755. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease (IPG769)

    We have moved interventional procedures guidance 769 to become HealthTech guidance 689. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. VA ECMO for severe acute heart failure in adults (IPG807)

    We have moved interventional procedures guidance 807 to become HealthTech guidance 764. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia (IPG798)

    We have moved interventional procedures guidance 798 to become HealthTech guidance 737. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Pharyngeal electrical stimulation for neurogenic dysphagia (IPG781)

    We have moved interventional procedures guidance 781 to become HealthTech guidance 709. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance